{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:22:29Z","timestamp":1791238949055,"version":"4.1.0"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2011,8,18]],"date-time":"2011-08-18T00:00:00Z","timestamp":1313625600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0023489","type":"journal-article","created":{"date-parts":[[2011,8,18]],"date-time":"2011-08-18T19:28:17Z","timestamp":1313695697000},"page":"e23489","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["The Use of Serum Glial Fibrillary Acidic Protein Measurements in the Diagnosis of Neuromyelitis Optica Spectrum Optic Neuritis"],"prefix":"10.1371","volume":"6","author":[{"given":"Mithu","family":"Storoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon T.","family":"Plant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,8,18]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archopht.126.7.994","article-title":"Treatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trial.","volume":"126","author":"RW Beck","year":"2008","journal-title":"Arch Ophthalmol"},{"issue":"23","key":"ref2","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","article-title":"NMO-IgG predicts the outcome of recurrent optic neuritis.","volume":"70","author":"M Matiello","year":"2008","journal-title":"Neurology"},{"issue":"9451","key":"ref3","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.","volume":"11\u201317;364","author":"VA Lennon","year":"2004","journal-title":"Lancet"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica.","volume":"6","author":"DM Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00417-010-1344-7","article-title":"Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica.","volume":"248","author":"M Nakamura","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"16","key":"ref6","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/WNL.0b013e3181f8832e","article-title":"IFN\u03b2-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum.","volume":"19;75","author":"J Shimizu","year":"2010","journal-title":"Neurology"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1136\/jnnp.51.11.1381","article-title":"Autoimmune optic neuropathy: evaluation and treatment.","volume":"51","author":"MJ Kupersmith","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0181-5512(08)71430-X","article-title":"[Recurrent inflammatory optic neuropathy].","volume":"31","author":"C Arndt","year":"2008","journal-title":"J Fr Ophtalmol"},{"issue":"Pt 2","key":"ref9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/brain\/awg045","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION).","volume":"126","author":"D Kidd","year":"2003","journal-title":"Brain"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial.","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"ref11","article-title":"Neuromyelitis optica and astrocytic damage in its pathogenesis.","author":"K Fujihara","year":"2011","journal-title":"J Neurol Sci"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/WNL.0b013e3181e2414b","article-title":"Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.","volume":"20;75","author":"R Takano","year":"2010","journal-title":"Neurology"},{"key":"ref13","article-title":"Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis.","author":"M Axelsson","year":"2011","journal-title":"J Neurol"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jnnp.2008.150698","article-title":"Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker.","volume":"80","author":"T Misu","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/jnnp.2003.017236","article-title":"Axonal degeneration and inflammation in acute optic neuritis.","volume":"75","author":"A Petzold","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d.","volume":"58","author":"CH Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica.","volume":"66","author":"DM Wingerchuk","year":"2006","journal-title":"Neurology"},{"issue":"1\u20132","key":"ref18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0022-1759(03)00189-3","article-title":"A specific ELISA for measuring neurofilament heavy chain phosphoforms.","volume":"278","author":"A Petzold","year":"2003","journal-title":"J Immunol Methods"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.65.7.913","article-title":"Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.","volume":"65","author":"P Waters","year":"2008","journal-title":"Arch Neurol"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0404.2010.01388.x","article-title":"Bilateral and recurrent optic neuritis in multiple sclerosis.","volume":"123","author":"J Burman","year":"2010","journal-title":"Acta Neurol Scand"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0023489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T14:36:02Z","timestamp":1540305362000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0023489"}},"subtitle":[],"editor":[{"given":"Steven","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,8,18]]},"references-count":20,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0023489","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,18]]}}}